Yahoo Malaysia Web Search

Sign In

Search results

  1. www.biogen.comHome | Biogen

    We work fearlessly and go beyond because we care deeply about making a difference and changing lives. If you are inspired by helping others, driven to discover transformative medicines, and want a career that can make a difference, we want to hear from you! Search open positions. Where science meets humanity.

    • Disease Areas

      Biogen acquired Reata Pharmaceuticals in September 2023, and...

    • Science & Innovation

      The potential to transform the lives of patients drives us...

    • Medicines

      Below is a list of our company's therapies. The below...

    • Responsibility

      As a purpose-driven company, we believe serving humanity...

  2. www.bloomberg.com › news › articlesBiogen to Pay Up to $1.8 Billion for Immune Drug Developer

    May 22, 2024 · Biogen Inc. agreed to acquire Human Immunology Biosciences Inc. for as much as $1.8 billion in a deal aimed at bolstering the biotechnology giant’s pipeline of immune disease treatments.

  3. www.biogen.com › science-and-innovationScience & Innovation | Biogen

    The potential to transform the lives of patients drives us at Biogen. Alzheimer’s Disease and Dementia. Our world-class neurology research and development organization is pushing toward novel approaches for previously intractable neurodegenerative conditions such as Alzheimer’s disease.

  4. www.thepharmaletter.com › biogentech-changes-name-to-cobalisBioGentech changes name to Cobalis - Pharmaceutical industry news...

    Jul 25, 2004 · California, USA-based BioGentech Corp says that, effective July 8, ithas changed its name to Cobalis Corp to reflect its transformation to a pharmaceutical company focused on over-the-counter anti-allergy medications.

  5. www.reuters.com › business › healthcare-pharmaceuticalsEisai and Biogen launch Alzheimer's drug Leqembi in China

    Jun 28, 2024 · June 28 (Reuters) - Eisai (4523.T) and Biogen (BIOAb.ST) have launched their Alzheimer's treatment Leqembi in China, the third country after the United States and Japan, the companies said on ...

  6. www.reuters.com › business › healthcare-pharmaceuticalsBiogen sees flat 2024 sales, pick up in Alzheimer's drug demand

    Feb 13, 2024 · Feb 13 (Reuters) - Biogen (BIIB.O) on Tuesday forecast flat 2024 product revenue as top-selling drugs face tough competition and sales of newer treatments take off slowly, but said there are...

  7. news.mit.edu › 2021 › mit-biogen-collaborate-address-climateMIT collaborates with Biogen on three-year, $7 million initiative...

    Nov 3, 2021 · MIT and Biogen have announced that they will collaborate with the goal to accelerate the science and action on climate change to improve human health. This collaboration is supported by a three-year, $7 million commitment from the company and the Biogen Foundation.